Notice2025-10065
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Application for Registration-DEA Form 225, Application for Registration Renewal-DEA Form 225a, Affidavit for Chain Renewal-DEA Form 225b
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 3, 2025
Issuing agencies
Justice Department
Abstract
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 105 (Tuesday, June 3, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 105 (Tuesday, June 3, 2025)]
[Notices]
[Pages 23569-23570]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-10065]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0012]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Extension of a Previously Approved Collection;
Application for Registration--DEA Form 225, Application for
Registration Renewal--DEA Form 225a, Affidavit for Chain Renewal--DEA
Form 225b
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 30 days until
July 3, 2025.
FOR FURTHER INFORMATION CONTACT: If you have comments especially on the
estimated public burden or associated response time, suggestions, or
need a copy of the proposed information collection instrument with
instructions or additional information, please contact Heather E.
Achbach, Regulatory Drafting and Policy Support Section, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
<a href="/cdn-cgi/l/email-protection#9fdbdadeb1cfcddedffbfafeb1f8f0e9"><span class="__cf_email__" data-cfemail="3d79787c136d6f7c7d59585c135a524b">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#571f3236233f322579127916343f3536343f1733323679303821"><span class="__cf_email__" data-cfemail="5e163b3f2a363b2c701b701f3d363c3f3d361e3a3b3f70393128">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on March 25, 2025, at 90
FR 13627, allowing for a 60-day comment period. Written comments and
suggestions from the public and affected agencies concerning the
proposed collection of information are encouraged. Your comments should
address one or more of the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and/or
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function and entering either the title of the information collection or
the OMB Control Number 1117-0012. This information collection request
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view
Department of Justice, information collections currently under review
by OMB.
DOJ seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOJ notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Overview of This Information Collection
1. Type of Information Collection: Extension without change of a
currently Approved Collection.
2. Title of the Form/Collection: Application for Registration,
Application for Registration Renewal, Affidavit for Chain Renewal.
3. Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: The form numbers are
DEA
[[Page 23570]]
Forms 225, 225a, and 225b. The applicable component within the
Department of Justice is the Drug Enforcement Administration, Diversion
Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: The Controlled Substances Act requires all businesses and
individuals who manufacture, distribute, import, export, and conduct
research and laboratory analysis with controlled substances to register
with the DEA. 21 U.S.C. 822, 21 CFR 1301.11 and 1301.13. Registration
is a necessary control measure that prevents diversion by ensuring the
closed system of distribution of controlled substances can be monitored
by the DEA and that the businesses and individuals handling controlled
substances are qualified to do so and are accountable.
5. Obligation to Respond: Required to Obtain or Retain Benefits.
6. Total Estimated Number of Respondents: 16,560.
7. Estimated Time per Respondent: 0.20066 hours.
8. Frequency: 1 per year.
9. Total Estimated Annual Time Burden: 3,323 hours.
10. Total Estimated Annual Other Costs Burden: $0.
If additional information is required, contact: Darwin Arceo,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, United States Department of Justice, Two
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.
Dated: May 29, 2025.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2025-10065 Filed 6-2-25; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 3, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.